Style Editor Docs
RadioGel™
Precision Radionuclide Therapy (PRnT)
Research (White Papers)
US FDA IDE Application Updates
US FDA IDE Pre-Submission Process
Human Clinical Trials
IsoPet®
Regional Clinics
IsoPet® Therapy Dog • Cat Application
IsoPet® Therapy Equine Application
IsoPet® Featured Therapy
Research (White Papers)
Survivor Stories
Brew (Dog)
Animal Studies
Canine Studies
Feline Studies
Our IsoPet® Mission
About
Management & Consultants
Advisory Boards
Contact - RadioGel™ | IsoPet®
Blog
Vivos Inc.
Press Releases
Board of Directors
SEC Filings
Contact - Investor Relations
Contact Us
RadioGel™
Precision Radionuclide Therapy (PRnT)
Research (White Papers)
US FDA IDE Application Updates
US FDA IDE Pre-Submission Process
Human Clinical Trials
IsoPet®
Regional Clinics
IsoPet® Therapy Dog • Cat Application
IsoPet® Therapy Equine Application
IsoPet® Featured Therapy
Research (White Papers)
Survivor Stories
Brew (Dog)
Animal Studies
Canine Studies
Feline Studies
Our IsoPet® Mission
About
Management & Consultants
Advisory Boards
Contact - RadioGel™ | IsoPet®
Blog
Vivos Inc.
Press Releases
Board of Directors
SEC Filings
Contact - Investor Relations
Sitemap
RadioGel™
Precision Radionuclide Therapy (PRnT)
Research (White Papers)
US FDA IDE Pre-Submission Process
Human Clinical Trials
IsoPet®
Regional Clinics
IsoPet® Therapy Dog • Cat Application
IsoPet® Therapy Equine Application
IsoPet® Featured Therapy
Research (White Papers)
Survivor Stories
Brew (Dog)
Animal Studies
Canine Studies
Feline Studies
Our IsoPet® Mission
About
Management & Consultants
Advisory Boards
Contact - RadioGel™ | IsoPet®
Blog
Vivos Inc.
Press Releases
Board of Directors
SEC Filings
Contact - Investor Relations
Blog
09/08/2023 - RadioGel™ - Radiotherapy Gel Patent Published Application
09/06/2023 - RadioGel™ - FDA IDE Progress Update
07/06/2023 - Vivos Inc. Q2 2023 Update | IsoPet® - RadioGel™
05/09/2023 - You suspect your Pet has cancer. What’s next?
05/01/2023 - Vivos April 2023 Update | IsoPet® - RadioGel™
04/03/2023 - Vivos March 2023 Update | IsoPet® - RadioGel™
02/28/2023 - Vivos February 2023 Update | IsoPet® - RadioGel™
02/10/2023 - Supply Chain Management | IsoPet® - RadioGel™
02/01/2023 - Vivos January Update
01/26/2023 - Path to FDA IDE Submission
01/10/2023 - Exubrion Therapeutics® and Vivos Inc. collaborate on joint abstract
01/03/2023 - Vivos December Update
12/29/2022 - Dr. John E. Heidrich, PHD, VCM joins our Veterinary Medicine Advisory Board
12/01/2022 - Vivos November Update
11/01/2022 - Vivos October Update
10/01/2022 - Vivos September Update
09/01/2022 - US FDA IDE Pre-Submission Progress Update
05/24/2022 - US FDA IDE Pre-Submission Meeting Summary
Scroll to top